Worldwide spread of lifestyle diseases and its importance for cardiovascular events

Drugs of Today

Volumn 42, Issue SUPPL. C, 2006, Pages 5-8

  Erdmann, Erland ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; HEALTH CARE COST; HUMAN; IMMOBILIZATION; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; OBESITY; PREVALENCE; REVIEW; SMOKING;

AGE FACTORS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; OBESITY; RISK FACTORS; SEX FACTORS; WORLD HEALTH;

EID: 33846455147     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. World Health Organization (1997 and 2003). www.heartstats.org
2. WHO Global InfoBase. (http://www.who. int/ncd_surveillance/infobase/web/ InfoB aseCommon).
3. http://www.iotf.org/aboutobesity.asp
4. Manson, J.E., Skerrett, P.J., Greenland, P., Vanltallie, T.B. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med 2004, 164(3): 249-58.
5. World Health Organization. (http://www.who.int/topics/obesity/en/).
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352(9131): 837-53.
7. The Scandinavian Simvastatin Survival Study (4S). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994, 344(8934): 1383-9.
8. Balkau, B., Eschwege, E., Papoz, L. et al. Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. BMJ 1993, 307(6899): 295-9.
9. Knowler, W.C., Barrett-Connor, E., Fowler, S.E. et al. for the Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346(6): 393-403.